Related Experiment Video

Updated: Apr 4, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination

Jinlian Wei, Yingrui Yang, Mengchen Lu

  • 1Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China. sunhaopeng@163.com.

Anti-Cancer Agents in Medicinal Chemistry
|September 8, 2015
PubMed

Insights

Restoring wild-type p53 tumor suppressor function is key for cancer treatment. Inhibiting MDM2

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The p53 protein is a crucial tumor suppressor involved in cell cycle arrest, apoptosis, and senescence.
  • Approximately 50% of human tumors harbor wild-type p53 with latent functions that could be therapeutically restored.
  • MDM2 (murine double minute 2) is the primary antagonist of p53, inhibiting its tumor-suppressive activities through degradation and transcriptional masking.

Purpose of the Study:

  • To review current inhibitors targeting MDM2 E3 ligase activity for cancer therapy.
  • To explore the mechanisms regulating MDM2 E3 ubiquitin ligase activity.
  • To understand how targeting MDM2 can restore p53 function in cancer.

Main Methods:

  • Literature review of studies on MDM2 E3 ligase inhibitors.
  • Analysis of the regulation of MDM2 E3 ubiquitin ligase activity.
  • Examination of MDM2's role in p53 degradation and cancer progression.

Main Results:

  • MDM2's E3 ligase activity is a critical target for reactivating p53.
  • Inhibitors of MDM2 E3 ligase activity are progressing rapidly as potential anticancer agents.
  • Understanding MDM2 regulation, including post-translational modifications and cofactor interactions, is vital for developing effective inhibitors.

Conclusions:

  • Targeting MDM2 E3 ligase activity offers a promising strategy to restore p53's tumor-suppressive functions.
  • Inhibitors of MDM2 E3 ligase may enable p53 to escape degradation and control tumor growth.
  • Further research into MDM2 regulation is essential for advancing MDM2-targeted cancer therapies.

More Related Videos

Detection of Protein Ubiquitination09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

43.9K
Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K